Biocon Limited — Board Meeting, 08-05-2025: Outcome of Board Meeting

Biocon has announced a board meeting on May 8, 2025, approving the financial results for the quarter and half-year. Consolidated revenue rose to Rs. 16,470 Cr with net profit at Rs. 1,429 Cr, up from Rs. 1,298 Cr. The Board proposed a final dividend of 10% (Rs. 0.50 per share). Biosimilars led growth with Rs. 9,017 Cr revenue, supported by gains in generics and research services. The company strengthened liquidity through debt refinancing and acquired a biologics manufacturing site in the US. Ms. Naina Lal Kidwai was re-appointed as Independent Director.